Automated antimicrobial susceptibility testing market analysis | Coherent Market Insights - PowerPoint PPT Presentation

About This Presentation
Title:

Automated antimicrobial susceptibility testing market analysis | Coherent Market Insights

Description:

Read here the latest updates on the Automated antimicrobial susceptibility testing market analysis published by the CMI team. – PowerPoint PPT presentation

Number of Views:84

less

Transcript and Presenter's Notes

Title: Automated antimicrobial susceptibility testing market analysis | Coherent Market Insights


1
Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • Covid-19 Impact Tracker

2
  • AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING
    MARKET ANALYSIS
  • Automated Antimicrobial Susceptibility Testing
    Market, By Product Type (Consumables and
    Instruments), By Detection Method (Turbidimetric
    and Colorimetric), By Application (Antibacterial
    (Tuberculosis and Sepsis), Antifungal,
    Anti-parasitic, and Anti-viral), By End User
    (Pharmaceutical and Biotechnology Companies,
    Contract Research Organizations, Hospitals, and
    Pathology/Diagnostic Laboratories), and By Region
    (North America, Latin America, Europe, Asia
    Pacific, Middle East, and Africa) Size, Share,
    Outlook, and Opportunity Analysis, 2018-2026

3
  • Automated antimicrobial susceptibility testing is
    extensively used to achieve minimum inhibitory
    concentration (MIC) results using an
    antimicrobial susceptibility testing system,
    which offers flexible, customizable testing
    options to accommodate laboratories of all sizes.
    Antimicrobial susceptibility testing (AST) aims
    to ensure that suitable antibiotics are
    prescribed to individuals by monitoring
    inhibition zone of antibiotics and emergence of
    resistant pathogens in infected individuals.
    Information on local patterns of antimicrobial
    susceptibility can be collected using
    antimicrobial susceptibility testing, so that
    policies guiding the therapy can be based on
    current data on local resistance trends or
    institutional antibiogram.
  • The global automated antimicrobial susceptibility
    testing market size was valued at US 1,295.5
    million in 2018 and is expected to witness a CAGR
    of 8.9 over the forecast period (2018 2026).

4
  • Global Automated Antimicrobial Susceptibility
    Testing Market Share () Analysis, By Product
    Type, 2018

5
  • Emergence of multidrug resistance worldwide is
    expected to drive growth of the automated
    antimicrobial susceptibility testing market
  • Increasing number of multidrug resistance cases
    in tuberculosis (TB), malaria, HIV, influenza,
    and others among the global population is
    expected to result in increasing adoption of
    antimicrobial susceptibility testing to reduce
    the resistance exposure during the forecast
    period. For instance, according to the World
    Health Organization (WHO), in 2014, there were
    around 480,000 new cases of multidrug-resistant
    tuberculosis (MDR-TB), a form of tuberculosis
    that is resistant to the two most powerful
    anti-TB drugs. Among these, only around 123,000
    cases were detected and reported.
  • Moreover, increasing number of product launches
    is also expected to highly contribute to the
    automated antimicrobial susceptibility testing
    market growth. For instance, in March 2016,
    Becton, Dickinson and Company launched the new BD
    Phoenix M50 ID/AST system, which helps to deliver
    the same rapid, accurate, and cost-effective
    testing as the legacy BD Phoenix 100, within a
    small footprint.

6
Automated Antimicrobial Susceptibility Testing
Market - Restraints
  • Challenges in automated antimicrobial
    susceptibility testing include stringent rules
    and regulations from regulatory bodies, which
    hinders growth of the automated antimicrobial
    susceptibility testing market size. For instance,
    in the European Union, antimicrobial
    susceptibility testing (AST) systems are
    regulated by the Directive 98/79/EC (IVD
    directive), which was changed in 2017 with the
    introduction of the Regulation 2017/746 of the
    European Parliament and of the Council. It
    requires design, development, and manufacturing
    to be performed under a quality system according
    to ISO 13485.

7
Automated Antimicrobial Susceptibility Testing
Market - Regional Insights
  • On the basis of region, the global automated
    antimicrobial susceptibility testing market is
    segmented into North America, Latin America,
    Europe, Asia Pacific, Middle East, and Africa.
    North America is expected to hold a dominant
    position in the global automated antimicrobial
    susceptibility testing market during the forecast
    period, owing to development of new antimicrobial
    testing procedures and increasing awareness among
    people regarding antimicrobial resistance (AMR).
    For instance, in April 2018, the U.S. Food and
    Drug Administration approved Thermo Scientific
    Sensititre ID/AST System, the first to offer
    delafloxacin and meropenem/vaborbactam on
    IVD-labeled, microbroth dilution susceptibility
    plates. The antimicrobials are currently
    available in the U.S. on Sensititre custom plates
    and are expected be available soon in new
    standard formats.
  • Asia Pacific is expected to witness rapid growth
    in the automated antimicrobial susceptibility
    testing market, owing to high prevalence of
    microbial infections and increasing consumption
    of antibiotics, eventually developing resistance
    among the population. For instance, according to
    a 2014 WHO report, multidrug-resistant
    tuberculosis rates were high in India, especially
    among those who were previously treated and
    treatment for the disease is generally limited.

8
Global Automated Antimicrobial Susceptibility
Testing Market Value (US Mn) Y-o-Y Growth (),
2016-2026
  • Automated Antimicrobial Susceptibility Testing
    Market - Competitive Landscape
  • Key players operating in the global automated
    antimicrobial susceptibility testing market
    include bioMérieux S.A., HiMedia Laboratories,
    Alifax Holding S.p.A., Creative Diagnostics,
    Resistell AG, Danaher Corporation, Becton,
    Dickinson and Company, Thermo Fisher Scientific
    Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

9
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//www.coherentmarketinsights.com/
    market-insight/automated-antimicrobial-susceptibil
    ity-testing-market-2622

10
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

11
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

12
Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
Write a Comment
User Comments (0)
About PowerShow.com